Recent Funding
Investors
Cambridge Innovation Capital

Cambridge Innovation Capital portfolio

Cambridge Innovation Capital has 11 portfolio companies on record at Recent Funding, with 7 investments in the last 12 months.

Website: cic.vc.

Type: Venture capital.

Portfolio on Recent Funding: 11.

Deals, last 12 months: 7.

Rounds led: 7 of 19.

Capital in their rounds: $1.65B.

Latest deal: Microbiotica · Oct 16, 2026.

About this page

It is a venture capital firm based in Cambridge, GB, founded in 2012. It led 7 of the 19 rounds it joined. Its most recent investment on record is Microbiotica's $47.69M Series B+ round in October 2026, alongside Seventure Partners, British Business Bank, Tencent and 3 others. By category, its portfolio leans toward Health and bio (7) and Developer tools and cloud (3). It has co-invested with Tencent, IP Group and Oxford Science Enterprises, most often Tencent (5 rounds).

About Cambridge Innovation Capital

Firm type: Venture capital.

Headquarters: Cambridge, GB.

Founded: 2012.

Stages: Seed, Series A, Series B, Series C, Growth, Late Stage.

Sectors: AI & Machine Learning, Biotech, Deep Tech, Healthtech, Impact & Social Good.

Check size: $127K to $12.7M.

Leads rounds: No.

Portfolio companies: 33.

Exits: 1.

Rounds led: 0.

What Cambridge Innovation Capital invests in

Cambridge Innovation Capital recent investments

Company	Round	Date	Alongside
MMicrobiotica	Series B+ · $47.69M	Oct 16, 2026	Seventure Partners, British Business Bank (lead), Tencent +3
SSalience Labs	Series B+ · $125M	Oct 14, 2026	Hudson River Trading, Bullhound Capital (lead), AMD Ventures +6
TTRIMTECH Therapeutics	Seed · $14M	Jun 23, 2026	Eli Lilly, Johnson & Johnson Innovation (lead), Cambridge Enterprise Ventures +5
TTrent AI	Seed · $13M · lead	Apr 7, 2026	none named
IImmutrin	Series A · $86.45M	Mar 26, 2026	Qiming Venture Partners, Cambridge Enterprise Ventures, SR One +2
BBeyondMath	Seed · $18.5M · lead	Feb 25, 2026	none named
TT-Therapeutics	Series A · $91M	Nov 13, 2025	Digitalis Ventures, Cambridge Enterprise Ventures, Tencent +4
SSortera Bio	Pre-seed · $10.14M · lead	Jun 4, 2025	BioNTech, AstraZeneca

How Cambridge Innovation Capital invests

Stage	Deals	Capital in rounds
Series B+	8 42%	$1.3B
Series A	5 26%	$282.51M
Seed	5 26%	$61.14M
Pre-seed	1 5%	$10.14M

Year	Deals	Capital in rounds
2016	1 5%	$16.06M
2019	2 11%	$246.24M
2021	1 5%	$600M
2022	3 16%	$108.5M
2023	3 16%	$242.66M
2025	3 16%	$131.14M
2026	6 32%	$304.64M

Cambridge Innovation Capital portfolio companies

MMicrobiotica$47.69MSeries B+ · Oct 2026
SSalience Labs$125MSeries B+ · Oct 2026
TTRIMTECH Therapeutics$14MSeed · Jun 2026
TTrent AI$13MSeed · Apr 2026
IImmutrin$86.45MSeries A · Mar 2026
BBeyondMath$18.5MSeed · Feb 2026
TT-Therapeutics$91MSeries A · Nov 2025
SSortera Bio$10.14MPre-seed · Jun 2025
CCMR Surgical$165MSeries B+ · Sep 2023
RRiverlane$18.66MSeries B+ · Apr 2023
SStorm Therapeutics$30MSeries B+ · Dec 2022

Company	Round with Cambridge Innovation Capital	Total raised	Latest raise
MMicrobiotica Health and bio	Oct 16, 2026 Series B+ · $47.69M	$114.69M	Oct 16, 2026 Series B+
SSalience Labs AI infrastructure and compute	Oct 14, 2026 Series B+ · $125M	$166.5M	Oct 14, 2026 Series B+
TTRIMTECH Therapeutics Health and bio	Jun 23, 2026 Seed · $14M	$45M	Jun 23, 2026 Seed
TTrent AI AI agents	Apr 7, 2026 Seed · $13M · lead	$13M	Apr 7, 2026 Seed
IImmutrin Health and bio	Mar 26, 2026 Series A · $86.45M	$86.45M	Mar 26, 2026 Series A
BBeyondMath Data and analytics	Feb 25, 2026 Seed · $18.5M · lead	$18.5M	Feb 25, 2026 Seed
TT-Therapeutics Health and bio	Nov 13, 2025 Series A · $91M	$150M	Nov 13, 2025 Series A
SSortera Bio Health and bio	Jun 4, 2025 Pre-seed · $10.14M · lead	$10.14M	Jun 4, 2025 Pre-seed
CCMR Surgical Health and bio	Sep 20, 2023 Series B+ · $165M	$1.41B	Oct 12, 2026 Series B+
RRiverlane	Apr 24, 2023 Series B+ · $18.66M	$97.8M	Aug 6, 2024 round
SStorm Therapeutics Health and bio	Dec 14, 2022 Series B+ · $30M · lead	$102.06M	Apr 16, 2026 Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-09, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 19 rounds on Recent Funding that name Cambridge Innovation Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Cambridge Innovation Capital, which is a subset of its real portfolio. API: /api/v1/investors/cambridge-innovation-capital (get a free API key). More: the most active VC firms and new venture capital funds.